Compound information
- Natural Products
- ZC159023
- Molecular Formula
- C12H15FN2O4S
- Molecular Weight
- 302.07365618 g/mol
- Structure
-
- IUPAC Name
- methyl 4-(4-fluorophenyl)sulfonylpiperazine-1-carboxylate
- InChI
- InChI=1S/C12H15FN2O4S/c1-19-12(16)14-6-8-15(9-7-14)20(17,18)11-4-2-10(13)3-5-11/h2-5H,6-9H2,1H3
- InChI Key
- NKSRXZBNFAUATJ-UHFFFAOYSA-N
- SMILES
- COC(=O)N1CCN(S(=O)(=O)c2ccc(F)cc2)CC1
- Source
- ZINC000001053764
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 20 | Ring Count | 2 |
Heteroatom Count | 8 | Rotatable Bond Count | 2 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 66.92 Å2 | LogP | 1.186 |
LogS | -2.264 | LogD | 1.499 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.022 | Pgp substrate | 0.025 |
HIA | 0.969 | F20 % | 0.993 |
F30 % | 0.94 | Caco-2 | -4.398 |
MDCK | -4.803 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.736 | PPB | 86.927 |
VD | 0.568 | Fu | 0.958 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.095 | CYP1A2 substrate | 0.49 |
CYP2A6 substrate | 0.434 | CYP2B6 substrate | 0.539 |
CYP2C19 inhibitor | 0.722 | CYP2C19 substrate | 0.803 |
CYP2C8 substrate | 0.74 | CYP2C9 inhibitor | 0.358 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.022 |
CYP2D6 substrate | 0.792 | CYP2E1 substrate | 0.596 |
CYP3A4 inhibitor | 0.035 | CYP3A4 substrate | 0.993 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.317 | CL | 5.162 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.22 | Hepatotoxicity | 0.972 |
Mutagenicity | 0.133 | Rat Oral Acute Toxicity | 0.278 |
FDAMDD | 0.6 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.877 | Eye Corrosion | 0.009 |
Eye Irritation | 0.031 | Respiratory Toxicity | 0.205 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.79 | IGC50 | 2.956 |
LC50FM | 0.34 | LC50DM | 1.988 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.349 | NR-AR-LBD | 0.355 |
NR-AhR | 0.047 | NR-Aromatase | 0.048 |
NR-ER | 0.281 | NR-ER-LBD | 0.368 |
NR-PPAR-gamma | 0.122 | SR-ARE | 0.176 |
SR-ATAD5 | 0.297 | SR-HSE | 0.06 |
SR-MMP | 0.011 | SR-p53 | 0.023 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.